Member Info for metis20

https://www.miningweekly.com/article/vladislav-sviblov-swoops-on-trans-siberian-gold-2021-03-18/rep_id:3650

https://www.morningstar.co.uk/uk/news/AN_1659705219768670800/in-brief-amur-minerals-enters-deal-to-dispose-of-kun-manie-project.aspx

This decree is about investors selling shares. It is not about a company, eg AMC, selling its resource.

https://www.reuters.com/markets/europe/russia-bans-western-investors-selling-stakes-banks-key-assets-including-sakhakin-2022-08-05/

Try this
https://www.nasdaq.com/market-activity/ipos/financial-filings?dealId=1121064-101505
and scroll down to the 07/25/2022 link

https://secfilings.nasdaq.com/filingFrameset.asp?FilingID=15964879&View=html (22_07_25)

"Approximate date of commencement of proposed sale to public: As soon as practicable after the effective date hereof."

"We anticipate that the initial public offering price of our Units will be between $7.50 and $9.50"

Thanks for the useful replies.

In my notes, I spotted this extract from this board a few days back

"I suppose the 5140 part is the key that fits in the FAPa lock. This would be because it has the right shape and chemical characteristics (hydrogen bonds, delocalised electons, positive and negative attractions) to interact with FAPa 's chemical structure and hold AVA6000 in place so that FAPa can pull on it enough to catalyse the hydrolysis of the link to the doxorubicin part. It must be this 5140 part that is the key as it is the only part that is common to all Avacta's prodrugs. It is the essence of the IP."

That all makes good sense, especially when coupled with "pre|CISION is designed to be a highly specific substrate for FAPa", which is an extract from a slide showing around 3:38 in https://avacta.wistia.com/medias/kv40kul5b2

Why have the posts suddenly reappeared?

Why have the posts on this board since 9:00 disappeared?

Via https://avacta.com/therapeutics/precision/ I found this:-

"When added to a chemotherapy, the pre|CISION™ substrate prevents the drug from entering cells and therefore renders it inert until the substrate is cleaved in the tumour microenvironment. Using this FAPa-activated approach, the systemic exposure to the chemotherapy is dramatically reduced, and the safety and therapeutic window of these powerful anti-cancer treatments is improved."

Which prompts me to ask what may well be a dumb question, is the pre|CISION™ substrate the same for AVA6000 as AVA3996?

NFC sp currently 1308p, so up 42p from the sp at the time of the offer. Pushes the value of the offer up from 247.2pps to 254.1pps.

"..significant synergies available to NFC.."
Looks as if, because of those significant synergies, Vin Murria is thinking that SAA is worth more to NFC than to ADVT.

Latest para. in the story - from today's RNS
"The Company believes that although NFC is a credible buyer, its offer price does not reflect the value of foregoing control and the significant synergies available to NFC."
"AdvancedAdvT and Vin Murria continue to consider their options."

Vin Murria may attempt to push NFC to a higher bid?

https://www.londonstockexchange.com/news-article/ADVT/response-to-press-comment/15463172

Vin Murria at 12:30
https://www.ukinvestorshow.com/may-2022-show/

Anyone hear Vin Murria speak at that show?

From richjp post on ADVFN this morning:-
Vin Murria was interviewed at the UK Investor Show in London yesterday. She spoke very positively about Next Fifteen and said that she believes they will take Saachi in the direction that she wanted to take the company in the first place.

https://www.londonstockexchange.com/news-article/ADVT/response-to-next-fifteen-offer-for-m-c-saatchi/15461588
"The board of AdvancedAdvT notes today's announcement by Next Fifteen Communications plc regarding its offer for M&C Saatchi plc.
The board of AdvancedAdvT is considering its options. A further announcement will be made as and when appropriate."

https://www.londonstockexchange.com/news-article/NFC/offer-for-m-c-saatchi-plc/15461206
"For each M&C Saatchi Share:
0.1637 of a New Next Fifteen Share and 40 pence in cash
The Acquisition values each M&C Saatchi Share at 247.2 pence (the "Acquisition Price") and the entire issued and to be issued ordinary share capital of M&C Saatchi at approximately £310.1 million on a fully diluted basis (the "Acquisition Value") based on the Closing Price per Next Fifteen Share on the Last Practicable Date of 1,266.0 pence."

"The M&C Saatchi Independent Directors are recommending the terms of the Acquisition and consider it superior to the terms of the ADV Offer which they have unanimously rejected. Accordingly the M&C Saatchi Independent Directors urge M&C Saatchi Shareholders to take no action in respect of the ADV Offer."

ITE:TSX closed 7.84% up yesterday at 55 Canadian cents.
This is equivalent to 34p
Mid price here currently is around 30.5p

https://www.londonstockexchange.com/news-article/CML/transaction-in-own-shares/15413174
150k at 355p yesterday
Daily average is only about 25k shares!
Share buyback programme announced yesterday
https://www.londonstockexchange.com/news-article/CML/share-buyback-programme/15411652

Corero Network Security plc (AIM: CNS), a leading provider of real-time, high-performance, automatic Distributed Denial of Service (DDoS) cyber defense solutions, will announce its results for the year ended 31 December 2021 on Tuesday, 26 April 2022.
In addition, the Company will be hosting a presentation for investors in relation to the Company's full year results on Thursday, 28 April 2022 at 1.00 p.m. BST.
hTTps://www.londonstockexchange.com/news-article/CNS/notice-of-results-investor-presentation/15410560

and for the 24 Jan FY trading update:-
hTTps://www.londonstockexchange.com/news-article/CNS/trading-update/15298342

Thanks Softrock. All now clear.

https://www.londonstockexchange.com/news-article/market-news/proposed-placing-in-atalaya-mining-plc/15393638

"The Placing will be conducted by means of an accelerated bookbuild secondary placing to institutional investors which will begin with immediate effect. The final price at which the Placing Shares are to be sold will be agreed by Canaccord Genuity Limited ("Canaccord Genuity") and ICBCS at the close of the bookbuild process. The results of the Placing will be announced as soon as practicable thereafter. ."

This suggests to me that the bookbuild process is not yet complete.